Metal poisoning;Intoxicación por metales

Anales del Sistema Sanitario de Navarra

Volumn 26, Issue SUPPL. 1, 2003, Pages 141-153

  Ferrer, Ana ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Arsenic; Lead; Mercury; Metals; Toxicity

Indexed keywords

ARSENIC; CHELATING AGENT; DEFEROXAMINE; DIMERCAPROL; EDETIC ACID; LEAD; MERCURY; METAL; PENICILLAMINE; SUCCIMER; UNITHIOL;

CHELATION THERAPY; CLINICAL FEATURE; HUMAN; INTOXICATION; POLLUTION; REVIEW; SOLUBILITY; TOXICOKINETICS;

ACUTE DISEASE; ARSENIC POISONING; HUMANS; LEAD POISONING; MERCURY POISONING; METALS;

EID: 0037868271     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. a Ed. New York: Wiley and sons. 1988.
2. WHO. Lead. Environmental Health Criteria 3. Geneva: WHO, 1977.
3. a Ed. Madrid: McGraw-Hill, 1998.
4. SULLIVAN JB, KRIEGER GR. Environmental Sciences: Pollutant Fate and Transport in the Environment. En: Sullivan JB, Krieger GR, editors. Clinical Environmental Health and Toxic Exposures. Philadelphia: Lippincott William and Wilkins, 2001: 6-30.
5. KURLAND LT, FARO SN, SIEDLER H. Minamata Disease. The Outbreak of a Neurologic Disorder in Minamata, Japan, and Its Relationship to the Ingestion of Seafood Contaminated by Mercury Compounds. World Neurol 1960; 1: 370-395.
6. FERRER A, CABRAL R. Collective poisoning by pesticides: mechanism of production-mechanism of prevention. Rev Environ Toxicol 1993; 5: 161-201.
7. RAHMAN MM, CHOWDHURY UK, MUKHERJEE SCH, MONDAL BK, PAUL K, LODH D et al. Chronic arsenic toxicity in Balgladesh and West Bengal, India- A review and commmentary. Clin Toxicol 2001; 39: 683-700.
8. o 100. Lyon: WHO IARC, 1990.
9. http://www.arc.fr.
10. AASETH J. Recent advances in the therapy of metal poisoning with chelating agents. Hum Toxicol 1983: 257-272.
11. a edición. Stamford: Appleton and Lange, 1998: 1274-1276.
12. a edición. Stamford: Appleton and Lange, 1998: 1310-1314.
13. a edición. Stamford: Appleton and Lange, 1998: 1310-1314.
14. NOGUÉ S. Protocolos de tratamiento de las intoxicaciones de la Sección de Toxicología Clínica de la Asociación Española de Toxicología. wzar.unizar.es/stc/index.htm
15. a edición. Stamford: Appleton and Lange, 1998: 1261-1273.
16. Agency for Toxic Substances and Disease Control. The nature and extent of lead poisoning in children in the United States: A report to Congress. Atlanta: ATSDR 1988.
17. KEOGH JP, BOYER LV. Lead. En: Sullivan JB, Krieger GR, editors. Clinical Environmental Health and Toxic Exposures. Philadelphia: Lippincott William and Wilkins, 2001: 879-889.
18. SILBERGELD EK, SCWARTZ J, MAHAFFEY K. Lead and osteoporosis: Mobilization of lead from bone in post-menopausal women. Environ Res 1988; 47: 79-94.
19. LANDGAN P. Current issues in the epidemiology and toxicology of occupational exposure to lead. Environ Health Perspect 1990; 89: 61-66.
20. PAGLIA DE, VALENTINE WN, DAHLGNER JG. Effects of low level lead exposure on pyrimidine-5′-nucleotidase and other erythrocyte enzymes. J Clin Invest 1976; 56: 1164-1169.
21. AUDESIRK G. Electrophysiology or lead intoxication: Effects on voltage-sensitive ions channels. Neurotoxicology 1993; 14: 137-147.
22. MARKOVAC J, GOLDSTEIN GW. Picomolar concentrations of lead stimulate brain protein kinase C. Nature 1988; 334:71-73.
23. VANDER AJ. Chronic effects of lead in rennin-angiotensin system. Environ Health Perspect 1988; 78: 7-83.
24. KOSMIDER S, PETELENZ T. Electrocardiographic changes in elderly patients with chronic lead poisoning. Pol Arch Med Wewn 1962; 32: 437-442.
25. a ed. Paris: Masson, 1990: 198-228.
26. a edición. Stamford: Appleton and Lange, 1998: 1315-1317.
27. WHO. Mercury. Environmental Health Criteria 1. Geneva: WHO, 1976.
28. YIP L, DART RC, SULLIVAN JB. Mercury. En: Sullivan JB, Krieger GR, editors. Clinical environmental health and toxic exposures. Philadelphia: Lippincott William and Wilkins, 2001: 867-879.
29. Agency for Toxic Substances and Disease Registry. Potential for human exposure. En: Toxicological profile for mercury. Atlanta: US Department of Health and Human Services, Public Health Service, ATSDR, 1992.
30. a ed. Paris: Masson, 1990: 170-191.
31. a edición. Stamford: Appleton and Lange, 1998: 1320-1331.
32. HURSH JB, CLAKSON TW, CHERIAN MG, VOSTAL JJ, MALLIE RV. Clearance of mercury (Hg-197, Hg-203) vapor inhaled by human subjects. Arch Environ Health 1976; 31: 302-309.
33. MAGOS L. Mercury. En: Seller HG, Sigel H, editores. Handbook on toxicity of inorganic compounds. New York: Marcel Dekker, 1988: 419-436.
34. WINSHIP KA. Organic mercury compounds and their toxicity. Adv Drug React Ac Pois Rev 1986; 3: 141-180.
35. GIMENEZ E. Experiencia Argentina: niños expuestos al acetato de fenilmercurio por vía percutánea. Sociedad Argentina de Toxicología 1981; 12: 12-17.
36. WARKANY J HUBBARD DM. Adverse mercurial reactions in the form of acrodynia and related conditions. Am J Dis Chil 1951; 81: 335-373.
37. WHO. Arsenic. Environmental Health Criteria 18. Geneva: WHO, 1981.
38. YIP L, DART RC. Arsenic. En: Sullivan JB, Krieger GR, editors. Clinical environmental health and toxic exposures. Philadelphia: Lippincott William and Wilkins, 2001: 858-866.
39. a edición. Stamford: Appleton and Lange, 1998: 1261-1273.
40. MEALEY J, BROWNELL GL, SWEET WH. Radioarsenic in plasma, urine normal tissues and intracraneal neoplasms. Arch Neurol Psychiatry 1959; 8: 310-320.
41. 3: its significance for the duration of BAL therapy. Clin Toxicol 1981; 18: 1067-1075.
42. GRESSER MJ. ADP-arsenato: Formation by sub-mitocondrial particles under phosphorylating conditions. J Biol Chem 1981; 256: 5981-5983.
43. a ed. Paris: Masson, 1990: 119-129.